Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mainz Biomed N.V. (MYNZ)

Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mainz Biomed N.V. ROBERT KOCH STRASSE 50 MAINZ 2M 55129 DEU

https://mainzbiomed.com Employees: 26 P: 131-554-2860

Sector:

Medical

Description:

Mainz Biomed N.V. develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. Mainz Biomed N.V. is based in BERKELEY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 9,442
Enterprise Value, $K 4,292
Shares Outstanding, K 8,584
Annual Sales, $ 890 K
Annual Net Income, $ -21,650 K
Last Quarter Sales, $ 210 K
Last Quarter Net Income, $ -5,180 K
EBIT, $ -26,650 K
EBITDA, $ -25,630 K
60-Month Beta 0.27
% of Insider Shareholders 18.20%
% of Institutional Shareholders 0.00%
Float, K 7,022
% Float 81.80%
Short Volume Ratio 0.50

Growth:

1-Year Return -80.08%
3-Year Return -99.61%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm -65.60
EPS Growth vs. Prev Year -10.38%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 12/03/24

MYNZ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -2,432.58%
Debt/Equity 0.19
Price/Sales 10.18
Price/Cash Flow N/A
Price/Book 1.92
Book Value/Share 0.55
Interest Coverage -19.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar